• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身免疫性肝炎联合治疗的疗效:一项系统评价与荟萃分析

Efficacy of Combination Therapies for Autoimmune Hepatitis: A Systematic Review and Meta-Analysis.

作者信息

Rashad Essam, Moazam Mustafa M, Chaudhry Raheel, El Eraky Noha, Mirza Muhammad Sohail S, Nazmin Farhana

机构信息

Hospital Medicine, Parkview Regional Medical Center, Fort Wayne, USA.

Psychiatry, Texas Tech University Health Sciences Center El Paso, El Paso, USA.

出版信息

Cureus. 2024 May 10;16(5):e60049. doi: 10.7759/cureus.60049. eCollection 2024 May.

DOI:10.7759/cureus.60049
PMID:38854256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11162748/
Abstract

Autoimmune hepatitis (AIH) is a hepatocellular disorder thought to be caused by an immune system that cannot tolerate autoantigens specific to hepatocytes. This study aims to evaluate the efficacy of using corticosteroids (prednisolone and azathioprine) as a combination therapy in treating AIH. This study aims to synthesize and analyze existing evidence to inform clinical practices concerning the overall clinical efficacy of this treatment approach in managing AIH. A comprehensive search was conducted across multiple online databases and search engines, including PubMed, Google Scholar, ScienceDirect, Medline, and Embase. RevMan 5.4 software was used for meta-analysis, with forest plots created for each outcome. Thirteen studies were included in this systematic review and meta-analysis. The results indicate that the combination of prednisolone and azathioprine for treating AIH leads to less recurrence and better disease control.

摘要

自身免疫性肝炎(AIH)是一种肝细胞疾病,被认为是由无法耐受肝细胞特异性自身抗原的免疫系统引起的。本研究旨在评估使用皮质类固醇(泼尼松龙和硫唑嘌呤)联合治疗AIH的疗效。本研究旨在综合和分析现有证据,为临床实践提供有关这种治疗方法在管理AIH方面的总体临床疗效的信息。在多个在线数据库和搜索引擎中进行了全面搜索,包括PubMed、谷歌学术、ScienceDirect、Medline和Embase。使用RevMan 5.4软件进行荟萃分析,并为每个结果创建森林图。本系统评价和荟萃分析纳入了13项研究。结果表明,泼尼松龙和硫唑嘌呤联合治疗AIH可减少复发并更好地控制疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd6/11162748/0b085d3ab184/cureus-0016-00000060049-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd6/11162748/581eb47f4cc6/cureus-0016-00000060049-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd6/11162748/040f92b8a7bf/cureus-0016-00000060049-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd6/11162748/6340d5f05fb0/cureus-0016-00000060049-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd6/11162748/0b085d3ab184/cureus-0016-00000060049-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd6/11162748/581eb47f4cc6/cureus-0016-00000060049-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd6/11162748/040f92b8a7bf/cureus-0016-00000060049-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd6/11162748/6340d5f05fb0/cureus-0016-00000060049-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd6/11162748/0b085d3ab184/cureus-0016-00000060049-i04.jpg

相似文献

1
Efficacy of Combination Therapies for Autoimmune Hepatitis: A Systematic Review and Meta-Analysis.自身免疫性肝炎联合治疗的疗效:一项系统评价与荟萃分析
Cureus. 2024 May 10;16(5):e60049. doi: 10.7759/cureus.60049. eCollection 2024 May.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.一项在初治自身免疫性肝炎患者中比较硫唑嘌呤与霉酚酸酯诱导缓解作用的开放性随机对照临床试验。
J Hepatol. 2024 Apr;80(4):576-585. doi: 10.1016/j.jhep.2023.11.032. Epub 2023 Dec 14.
4
Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysis.1970 - 2022年自身免疫性肝炎的全球发病率和患病率:一项系统评价和荟萃分析
EClinicalMedicine. 2023 Oct 17;65:102280. doi: 10.1016/j.eclinm.2023.102280. eCollection 2023 Nov.
5
Autoimmune hepatitis treatment in the elderly: A systematic review.老年人自身免疫性肝炎的治疗:系统评价。
World J Gastroenterol. 2019 Jun 14;25(22):2809-2818. doi: 10.3748/wjg.v25.i22.2809.
6
First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients.初发未治疗自身免疫性肝炎患者霉酚酸酯与硫唑嘌呤倾向性匹配试验的结果。
Front Immunol. 2022 Jan 11;12:798602. doi: 10.3389/fimmu.2021.798602. eCollection 2021.
7
Treatment of Overlap Syndromes in Autoimmune Liver Disease: A Systematic Review and Meta-Analysis.自身免疫性肝病重叠综合征的治疗:一项系统评价与Meta分析
J Clin Med. 2020 May 13;9(5):1449. doi: 10.3390/jcm9051449.
8
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.评估霉酚酸酯与硫唑嘌呤治疗自身免疫性肝炎的疗效和安全性(CAMARO 试验):一项随机对照试验的研究方案。
Trials. 2022 Dec 13;23(1):1012. doi: 10.1186/s13063-022-06890-w.
9
Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials.自身免疫性肝炎的治疗选择:一项随机对照试验的系统评价。
J Hepatol. 2010 Jul;53(1):191-8. doi: 10.1016/j.jhep.2010.01.037. Epub 2010 Mar 30.
10
Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia.自身免疫性肝炎:沙特阿拉伯单中心的临床表现、治疗反应和预后经验。
Saudi J Gastroenterol. 2010 Apr-Jun;16(2):95-9. doi: 10.4103/1319-3767.61235.

本文引用的文献

1
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial.帕米帕利联合替雷利珠单抗治疗晚期实体瘤患者的多中心、开放标签、1a/b 期剂量递增研究结果。
Lancet Oncol. 2019 Sep;20(9):1306-1315. doi: 10.1016/S1470-2045(19)30396-1. Epub 2019 Aug 1.
2
Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis.两种不同泼尼松龙方案治疗自身免疫性肝炎的疗效与结局
Dig Dis Sci. 2017 Oct;62(10):2900-2907. doi: 10.1007/s10620-017-4728-2. Epub 2017 Sep 4.
3
Evaluation of the effectiveness of treatment with prednisone and azathioprine of autoimmune hepatitis in children.
泼尼松和硫唑嘌呤治疗儿童自身免疫性肝炎的疗效评估。
Prz Gastroenterol. 2016;11(1):18-23. doi: 10.5114/pg.2015.52566. Epub 2015 Jun 29.
4
Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes.韩国自身免疫性肝炎-原发性胆汁性肝硬化重叠综合征的回顾性分析:特征、治疗及结局
Clin Mol Hepatol. 2015 Jun;21(2):150-7. doi: 10.3350/cmh.2015.21.2.150. Epub 2015 Jun 26.
5
Management of autoimmune hepatitis: Focus on pharmacologic treatments beyond corticosteroids.自身免疫性肝炎的管理:关注皮质类固醇以外的药物治疗。
World J Hepatol. 2014 Jun 27;6(6):410-8. doi: 10.4254/wjh.v6.i6.410.
6
Combination therapy of ursodeoxycholic Acid and corticosteroids for primary biliary cirrhosis with features of autoimmune hepatitis: a meta-analysis.熊去氧胆酸与皮质类固醇联合治疗具有自身免疫性肝炎特征的原发性胆汁性肝硬化:一项荟萃分析。
Gastroenterol Res Pract. 2013;2013:490731. doi: 10.1155/2013/490731. Epub 2013 Dec 4.
7
Autoimmune hepatitis.自身免疫性肝炎。
Dig Dis. 2013;31(1):155-63. doi: 10.1159/000347211. Epub 2013 Jun 17.
8
Autoimmune hepatitis.自身免疫性肝炎。
Lancet. 2013 Oct 26;382(9902):1433-44. doi: 10.1016/S0140-6736(12)62163-1. Epub 2013 Jun 14.
9
Liver transplantation in autoimmune liver diseases.自身免疫性肝病的肝移植。
Best Pract Res Clin Gastroenterol. 2011 Dec;25(6):765-82. doi: 10.1016/j.bpg.2011.09.008.
10
Therapeutic strategies for autoimmune hepatitis.自身免疫性肝炎的治疗策略。
Dig Dis. 2011;29(4):411-5. doi: 10.1159/000329805. Epub 2011 Aug 30.